Serum Amyloid P Is a Sialylated Glycoprotein Inhibitor of Influenza A Viruses

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Job, Emma R ^a   Bottazzi, Barbara ^b   Gilbertson, Brad ^a   Edenborough, Kathryn M ^a   Brown, Lorena E ^a   Mantovani, Alberto ^b,c   Brooks, Andrew G ^a   Reading, Patrick C ^a,d  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d WHO COLLABORATING CENTRE FOR REFERENCE AND RESEARCH ON INFLUENZA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA (2,6) LINKED SIALIC ACID; C REACTIVE PROTEIN; COMPLEMENT COMPONENT C1Q; INFLUENZA VIRUS HEMAGGLUTININ; PENTRAXIN 3; SERUM AMYLOID P; SIALIC ACID; SIALIDASE; SIALOGLYCOPROTEIN; SURFACTANT PROTEIN A; SURFACTANT PROTEIN D; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN CELL; INFLUENZA VIRUS A; INNATE IMMUNITY; MOLECULAR RECOGNITION; NONHUMAN; PROTEIN EXPRESSION; RECEPTOR BINDING; RESIDUE ANALYSIS; VIRUS HEMAGGLUTINATION; VIRUS INHIBITION; VIRUS MUTANT; VIRUS NEUTRALIZATION; VIRUS STRAIN;

ANIMALS; ANTIVIRAL AGENTS; C-REACTIVE PROTEIN; CALCIUM; COMPLEMENT C1Q; DOGS; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; HYDROLYSIS; INFLUENZA A VIRUS; INFLUENZA, HUMAN; MADIN DARBY CANINE KIDNEY CELLS; MANNOSE-BINDING LECTIN; MUTATION; N-ACETYLNEURAMINIC ACID; NEURAMINIDASE; NEUTRALIZATION TESTS; PROTEIN BINDING; PULMONARY SURFACTANT-ASSOCIATED PROTEIN D; RECEPTORS, VIRUS; SERUM AMYLOID P-COMPONENT; SPECIES SPECIFICITY;

BACTERIA (MICROORGANISMS); INFLUENZA A VIRUS; SUS;

EID: 84875476193     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0059623     Document Type: Article

References (78)

1. Gottschalk A, Belyavin G, Biddle F (1972) Glycoproteins. Their composition, structure and function; Gottschalk A, editor. New York: Elsevier.
2. Krizanova O, Rathova V, (1969) Serum inhibitors of myxoviruses. Curr Top Microbiol Immunol 47: 125-151.
3. Anders EM, Hartley CA, Jackson DC (1990) Bovine and mouse serum β inhibitors of influenza A viruses are mannose-binding lectins. PNAS 87.
4. White MR, Crouch E, van Eijk M, Hartshorn M, Pemberton L, et al. (2004) Cooperative anti-influenza act of respiratory innate immune proteins and neuraminidase inhibitor. Am J Physiol Lung Cell Mol Physiol 288: 831-840.
5. Hartshorn KL, White MR, Shepherd V, Reid K, Jensenius JC, et al. (1997) Mechanisms of anti-influenza activity of surfactant proteins A and D: comparison with serum protection. Am J Physiol 273: 1156-1166.
6. Tecle T, White MR, Crouch EC, Hartshorn KL, (2007) Inhibition of influenza viral neuraminidase activity by collectins. Arch Virol 152: 1731-1742.
7. Crouch E, Hartshorn K, Ofek I, (2000) Collectins and pulmonary innate immunity. Immunol Rev 173: 52-65.
8. Ng WC, Tate MD, Brooks AG, Reading PC, (2012) Soluble host defense lectins in innate immunity to influenza virus. J Biomed Biotechnol 2012: 732191.
9. Haagsman HP, Hogenkamp A, van Eijk M, Veldhuizen EJ, (2008) Surfactant collectins and innate immunity. Neonatology 93: 288-294.
10. Hartshorn KL, Crouch E, White MR, Eggleton P, Tauber AI, et al. (1994) Evidence for a protective role of pulmonary surfactant protein D (SP-D) against influenza A viruses. J Clin Invest 94: 311-319.
11. Reading PC, Morey LS, Crouch E, Anders EM, (1997) Collectin-mediated antiviral host defense of the lung: evidence from influenza virus infection of mice. J Virol 71: 8204-8212.
12. Hartshorn KL, White MR, Mogues T, Ligtenberg T, Crouch E, et al. (2003) Lung and salivary scavenger receptor glycoprotein-340 contribute to the host defense against influenza A viruses. Am J Physiol Lung Cell Mol Physiol 285: L1066-1076.
13. Fidler KJ, Hilliard TN, Bush A, Johnson M, Geddes DM, et al. (2009) Mannose-binding lectin is present in the infected airway: a possible pulmonary defence mechanism. Thorax 64: 150-155.
14. Jambo KC, French N, Zijlstra E, Gordon SB, (2007) AIDS patients have increased surfactant protein D but normal mannose binding lectin levels in lung fluid. Respir Res 8: 42.
15. Hawgood S, Brown C, Edmondson J, Stumbaugh A, Allen L, et al. (2004) Pulmonary collectins modulate strain-specific influenza a virus infection and host responses. J Virol 78: 8565-8572.
16. Le Vine AM, Whitsett J, Hartshorn KL, Crouch E, Korfhagen T, (2001) Surfactant protein D enhances clearance of influenza A virus from the lung in vivo. J Immunol 167: 5868-5873.
17. Vigerust DJ, Ulett KB, Boyd KL, Madsen J, Hawgood S, et al. (2007) N-linked glycosylation attenuates H3N2 influenza viruses. J Virol 81: 8593-8600.
18. Chang WC, White MR, Moyo P, McClear S, Thiel S, et al. (2010) Lack of the pattern recognition molecule mannose-binding lectin increases susceptibility to influenza A virus infection. BMC Immunol 11: 64.
19. Hanaoka K, Pritchett TJ, Takasaki S, Kochibe N, Sabesan S, et al. (1989) 4-O-acetyl-N-acetylneuraminic acid in the N-linked carbohydrate structures of equine and guinea pig alpha 2-macroglobulins, potent inhibitors of influenza virus infection. J Biol Chem 264: 9842-9849.
20. Pritchett TJ, Paulson JC, (1989) Basis for the potent inhibition of influenza virus infection by equine and guinea pig alpha 2-macroglobulin. J Biol Chem 264: 9850-9858.
21. Benne CA, Kraaijeveld CA, van Strijp JA, Brouwer E, Harmsen M, et al. (1995) Interactions of surfactant protein A with Influenza A viruses: binding and neutralisation. J Infect Dis 171: 335-341.
22. van Eijk M, White MR, Crouch EC, Batenburg JJ, Vaandrager AB, et al. (2003) Porcine pulmonary collectins show distinct interactions with influenza A viruses: role of the N-linked oligosaccharides in the carbohydrate recognition domain. J Immunol 171: 1431-1440.
23. Mikerov AN, White M, Hartshorn K, Wang G, Floros J, (2008) Inhibition of hemagglutination activity of influenza A viruses by SP-A1 and SP-A2 variants expressed in CHO cells. Med Microbiol Immunol 197: 9-12.
24. van Eijk M, White MR, Batenburg JJ, Vaandrager AB, van Golde LM, et al. (2004) Interactions of influenza A virus with sialic acids present on porcine surfactant protein D. Am J Respir Cell Mol Biol. 30: 871-879.
25. Deban L, Bottazzi B, Garlanda C, de la Torre YM, Mantovani A, (2009) Pentraxins: multifunctional proteins at the interface of innate immunity and inflammation. Biofactors 35: 138-145.
26. Manfredi AA, Rovere-Querini P, Bottazzi B, Garlanda C, Mantovani A, (2008) Pentraxins, humoral innate immunity and tissue injury. Curr Opin Immunol 20: 538-544.
27. Reading PC, Bozza S, Gilbertson B, Tate M, Moretti S, et al. (2008) Antiviral activity of the long pentraxin PTX3 against influenza viruses. J immunol 180: 3391-3398.
28. Andersen O, Ravan K, Sorensen I, Jonson G, Nielsen E, et al. (1997) Serum amyloid P component binds to influenza A virus hemagglutinin and inhibits the virus infection in vitro. Scandinavian Journal of Immunology 46: 331-337.
29. Horvath A, Andersen I, Junker K, Fogh-Schultz B, Nielsen E, et al. (2001) Serum amyloid P component inhibits influenza A virus infections: in vitro and in vivo studies. Antiviral research 52: 43-53.
30. Kilbourne ED, (1969) Future influenza vaccines and the use of genetic recombinants. Bull World Health Organ 41: 643-645.
31. Anders EM, Hartley CA, Reading PC, Ezekowitz RA, (1994) Complement-dependent neutralization of influenza virus by a serum mannose-binding lectin. J Gen Virol 75 (Pt 3): 615-622.
32. Hoffmann E, Krauss S, Perez D, Webby R, Webster RG, (2002) Eight-plasmid system for rapid generation of influenza virus vaccines. Vaccine 20: 3165-3170.
33. Hawkins PN, Tennent GA, Woo P, Pepys MB, (1991) Studies in vivo and in vitro of serum amyloid P component in normals and in a patient with AA amyloidosis. Clin Exp Immunol 84: 308-316.
34. Bottazzi B, Vouret-Craviari V, Basone A, De Gioia L, Matteucci C, et al. (1997) Multimer formation and ligand recognition by the long pentraxin PTX3. Similarities and differences with the short pentraxins C-reactive protein and serum amyloid P. J Biol Chem 272: 32817-32823.
35. Dean MM, Heatley S, Minchinton RM, (2006) Heteroligomeric forms of codon 54 mannose binding lectin (MBL) in circulation demonstrate reduced in vitro function. Mol Immunol 43: 950-961.
36. Brown LE, Ward CW, Jackson DC, (1982) Antigenic determinants of influenza virus hemagglutinin-IX. The carbohydrate side chains from an Asian strain. Mol Immunol 19: 329-338.
37. Rogers GN, Paulson JC, (1983) Receptor determinants of human and animal influenza virus isolates: differences in receptor specificity of the H3 hemagglutinin based on species of origin. Virology 127: 361-373.
38. Hoffmann E, Stech J, Guan Y, Webster RG, Perez DR, (2001) Universal primer set for the full-length amplification of all influenza A viruses. Arch Virol 146: 2275-2289.
39. Nobusawa E, Aoyama T, Kato H, Suzuki Y, Tateno Y, et al. (1991) Comparison of complete amino acid sequences and receptor-binding properties among 13 serotypes of hemagglutinins of influenza A viruses. Virology 182: 475-485.
40. Hartley CA, Jackson DC, Anders EM, (1992) Two distinct serum mannose-binding lectins function as β inhibitors of influenza virus: identification of bovine serum β inhibitor as conglutinin. J Virol 66: 4358-4363.
41. Corfield AP, Higa H, Paulson JC, Schauer R, (1983) The specificity of viral and bacterial sialidases for alpha(2-3)- and alpha(2-6)-linked sialic acids in glycoproteins. Biochim Biophys Acta 744: 121-126.
42. Inforzato A, Peri G, Doni A, Garlanda C, Mantovani A, et al. (2006) Structure and function of the long pentraxin PTX3 glycosidic moiety: fine-tuning of the interaction with C1q and complement activation. Biochemistry 45: 11540-11551.
43. Pepys MB, Rademacher TW, Amatayakul-Chantler S, Williams P, Noble GE, et al. (1994) Human serum amyloid P component is an invariant constituent of amyloid deposits and has a uniquely homogeneous glycostructure. Proc Natl Acad Sci U S A 91: 5602-5606.
44. Ryan-Poirier K, Suzuki Y, Bean WJ, Kobasa D, Takada A, et al. (1998) Changes in H3 influenza A virus receptor specificity during replication in humans. Virus Res 56: 169-176.
45. Tecle T, White MR, Sorensen G, Gantz D, Kacak N, et al. (2008) Critical role for cross-linking of trimeric lectin domains of surfactant protein D in antiviral activity against influenza A virus. Biochem J 412: 323-329.
46. Rogers GN, Paulson JC, Daniels RS, Skehel JJ, Wilson IA, et al. (1983) Single amino acid substitutions in influenza haemagglutinin change receptor binding specificity. Nature 304: 76-78.
47. Anders EM, Scalzo AA, Rogers GN, White DO, (1986) Relationship between mitogenic activity of influenza viruses and the receptor-binding specificity of their hemagglutinin molecules. J Virol 60: 476-482.
48. Verma A, White M, Vathipadiekal V, Tripathi S, Mbianda J, et al. (2012) Human H-ficolin inhibits replication of seasonal and pandemic influenza A viruses. J Immunol 189: 2478-2487.
49. Hartshorn KL, Ligtenberg A, White MR, Van Eijk M, Hartshorn M, et al. (2006) Salivary agglutinin and lung scavenger receptor cysteine-rich glycoprotein 340 have broad anti-influenza activities and interactions with surfactant protein D that vary according to donor source and sialylation. Biochem J 393: 545-553.
50. van Eijk M, H vdLC, Batenburg JJ, Vaandrager AB, Meschi J, et al. (2002) Porcine surfactant protein D is N-glysoylated in its carbohydrate recognition domain and is assembled into differently charged oligomers. Am J Respir Cell Mol Biol 26: 739-747.
51. Connor RJ, Kawaoka Y, Webster RG, Paulson JC, (1994) Receptor specificity in human, avian, and equine H2 and H3 influenza virus isolates. Virology 205: 17-23.
52. Dwek RA, Edge CJ, Harvey DJ, Wormald MR, Parekh RB, (1993) Analysis of glycoprotein-associated oligosaccharides. Annu Rev Biochem 62: 65-100.
53. Schauer R, (2000) Achievements and challenges of sialic acid research. Glycoconj J 17: 485-499.
54. Angata T, Varki A, (2002) Chemical diversity in the sialic acids and related alpha-keto acids: an evolutionary perspective. Chem Rev 102: 439-469.
55. Kottgen E, Hell B, Kage A, Tauber R, (1992) Lectin specificity and binding characteristics of human C-reactive protein. J Immunol 149: 445-453.
56. Das T, Sen AK, Kempf T, Pramanik SR, Mandal C, (2003) Induction of glycosylation in human C-reactive protein under different pathological conditions. Biochem J 373: 345-355.
57. Das T, Mandal C, (2004) Variations in binding characteristics of glycosylated human C-reactive proteins in different pathological conditions. Glycoconj J 20: 537-543.
58. Tennent GA, Pepys MB, (1994) Glycobiology of the pentraxins. Biochem Soc Trans 22: 74-79.
59. Baltz ML, De Beer FC, Feinstein A, Pepys MB, (1982) Calcium-dependent aggregation of human serum amyloid P component. Biochim Biophys Acta 701: 229-236.
60. Thompson D, Pepys MB, Tickle I, Wood S, (2002) The structures of crystalline complexes of human serum amyloid P component with its carbohydrate ligand, the cyclic pyruvate acetal of galactose. J Mol Biol 320: 1081-1086.
61. Dong A, Caughey WS, Du Clos TW, (1994) Effects of calcium, magnesium, and phosphorylcholine on secondary structures of human C-reactive protein and serum amyloid P component observed by infrared spectroscopy. J Biol Chem 269: 6424-6430.
62. Bottazzi B, Garlanda C, Salvatori G, Jeannin P, Manfredi A, et al. (2006) Pentraxins as a key component of innate immunity. Curr Opin Immunol 18: 10-15.
63. Garlanda C, Bottazzi B, Bastone A, Mantovani A, (2005) Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility. Annu Rev Immunol 23: 337-366.
64. Farberman MM, Akers KT, Malone JP, Erdman-Gilmore P, Townsend RR, et al. (2010) Airway proteins involved in bacterial clearance susceptible to cathepsin G proteolysis. Eur Respir J 35: 410-417.
65. Hartshorn KL, Sastry K, White MR, Anders EM, Super M, et al. (1993) Human mannose-binding protein functions as an opsonin for influenza A viruses. J Clin Invest 91: 1414-1420.
66. Kase T, Suzuki Y, Kawai T, Sakamoto T, Ohtani K, et al. (1999) Human mannan-binding lectin inhibits the infection of influenza A virus without complement. Immunology 97: 385-392.
67. Ezekowitz RA, Kuhlman M, Groopman JE, Byrn RA, (1989) A human serum mannose-binding protein inhibits in vitro infection by the human immunodeficiency virus. J Exp Med 169: 185-196.
68. Gomi K, Tokue Y, Kobayashi T, Takahashi H, Watanabe A, et al. (2004) Mannose-binding lectin gene polymorphism is a modulating factor in repeated respiratory infections. Chest 126: 95-99.
69. Murray LA, Rosada R, Moreira AP, Joshi A, Kramer MS, et al. (2010) Serum amyloid P therapeutically attenuates murine bleomycin-induced pulmonary fibrosis via its effects on macrophages. PLoS One 5: e9683.
70. Moreira AP, Cavassani KA, Hullinger R, Rosada RS, Fong DJ, et al. (2010) Serum amyloid P attenuates M2 macrophage activation and protects against fungal spore-induced allergic airway disease. J Allergy Clin Immunol 126: 712-721 e717.
71. Sweet C, Smith H, (1980) Pathogenicity of influenza virus. Microbiol Rev 44: 303-330.
72. Ibricevic A, Pekosz A, Walter MJ, Newby C, Battaile JT, et al. (2006) Influenza virus receptor specificity and cell tropism in mouse and human airway epithelial cells. J Virol 80: 7469-7480.
73. Wilks S, de Graaf M, Smith DJ, Burke DF, (2012) A review of influenza haemagglutinin receptor binding as it relates to pandemic properties. Vaccine 30: 4369-4376.
74. Herbert J, Hutchinson W, Carr J, Ives J, Jakob-Roetne R, et al. (2002) Influenza virus infection is not affected by serum amyloid P component. Molecular Medicine 8: 9-15.
75. Hensley SE, Das SR, Bailey AL, Schmidt LM, Hickman HD, et al. (2009) Hemagglutinin receptor binding avidity drives influenza A virus antigenic drift. Science 326: 734-736.
76. Tate MD, Brooks AG, Reading PC, (2011) Correlation between sialic acid expression and infection of murine macrophages by different strains of influenza virus. Microbes Infect 13: 202-207.
77. Suzuki Y, Nagao Y, Kato H, Matsumoto M, Nerome K, et al. (1986) Human influenza A virus hemagglutinin distinguishes sialyloligosaccharides in membrane-associated gangliosides as its receptor which mediates the adsorption and fusion processes of virus infection. Specificity for oligosaccharides and sialic acids and the sequence to which sialic acid is attached. J Biol Chem 261: 17057-17061.
78. Jayaraman A, Chandrasekaran A, Viswanathan K, Raman R, Fox JG, et al. (2012) Decoding the distribution of glycan receptors for human-adapted influenza A viruses in ferret respiratory tract. PLoS One 7: e27517.